Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Long-Term Investments for 3 consecutive years, with $30.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Long-Term Investments fell 22.77% year-over-year to $30.5 million in Q4 2025; TTM through Dec 2025 was $30.5 million, a 22.77% decrease from a year earlier, with the FY2025 full-year figure at $31.0 million, down 20.42% from the prior year.
• Long-Term Investments was $30.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $39.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $39.5 million in Q4 2024 and troughed at $30.5 million in Q4 2025.
• A 3-year average of $36.0 million and a median of $37.9 million in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments grew 4.32% in 2024 and decreased 22.77% in 2025, its largest moves.
• Over 3 years, Long-Term Investments stood at $37.9 million in 2023, then climbed by 4.32% to $39.5 million in 2024, then dropped by 22.77% to $30.5 million in 2025.
• The last three Long-Term Investments figures came in at $30.5 million (Q4 2025), $39.5 million (Q4 2024), and $37.9 million (Q4 2023), per Business Quant data.